A registered PHASE2, PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 2, Phase 3
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · NONE
- Evidence population
- Human clinical study registration
- Participants
- 526
- Population
- ALL · 70 Years
- Duration
- 2025-09-01 to 2030-12-01
- Intervention
- Comprehensive Geriatric Assessment
- Comparator
- Control group
- Outcomes measured
- Comprehensive Complex Index (CCI) value — 90 days after surgery; Quality of life scale: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC…; Quality of life scale EQ-5D-5L — at 3, 6 and 12 months post surgery; Quality of life scale ELD14 — at 3, 6 and 12 months post surgery; Discharge status — 90 days after surgery; All-cause mortality at 90 days after surgery — at 3 months post surgery; complication occurence and classification — at 3 months post surgery; Post-operative hospital length of stay (in days) — through study completion (an average of 5.5 years); Post-operative ICU length of stay (in days) — through study completion (an average of 5.5 years); Loss of independence at 3 months after surgery — 90 days after surgery; Time (in days) between the date of randomization and the date of surgery — from randomization to surgery, a maximum of…; Overall survival — at 12 months post surgery; time from surgery to cancer recurrence or death from any cause — through study completion (an average of 5.5 years); Percentage of patients that completed the geriatric intervention — through study completion (an average of 5.5 years); Percentage of patients contraindicated to surgery after CGA — through study completion (an average of 5.5 years); Time (in days) between the dates of randomization and preoperative geriatric consultation — through study completion (a…; Time (in days) between the dates of preoperative geriatric consultation and onset of tailored interventions — through s…; Time (in days) between the dates of preoperative geriatric consultation and surgery — through study completion (an aver…
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.